Descartes Announces Fiscal 2023 Second Quarter Financial Results

Record Revenues and Income from Operations WATERLOO, Ontario, Sept. 07, 2022 (GLOBE NEWSWIRE) — The Descartes Systems Group Inc. (TSX:DSG) (Nasdaq:DSGX) announced its financial results for its fiscal 2023 second quarter (Q2FY23). All financial results referenced are in United States (US) currency and, unless otherwise indicated, are determined in accordance […] Lire la suite »

Merus Announces Poster Presentation on MCLA-129 at the 34th EORTC/NCI/AACR Symposium on Molecular Targets and Cancer Therapeutics

UTRECHT, The Netherlands and CAMBRIDGE, Mass., Sept. 07, 2022 (GLOBE NEWSWIRE) — Merus N.V. (Nasdaq: MRUS) (“Merus”, “the Company”, “we”, or “our”), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics® and Triclonics®), today announced the selection of an abstract for a poster presentation at the 34th EORTC/NCI/AACR Symposium […] Lire la suite »

Teilnahme von atai Life Sciences an Investorenveranstaltungen im September

NEW YORK und BERLIN, Sept. 07, 2022 (GLOBE NEWSWIRE) — atai Life Sciences N.V. (Nasdaq: ATAI) („atai“), ein biopharmazeutisches Unternehmen für den klinischen Bereich, das sich der Aufgabe verschrieben hat, die Behandlung von psychischen Erkrankungen zu transformieren, wird im September an den folgenden Investorenkonferenzen teilnehmen: 17. jährliche BioPharma-Konferenz von Citi […] Lire la suite »

eGain se connecte à IBM Watson Assistant pour un service plus intelligent

SUNNYVALE, Californie, 07 sept. 2022 (GLOBE NEWSWIRE) — eGain Corporation (NASDAQ : EGAN), le principal fournisseur de plateformes d’automatisation des connaissances pour l’engagement client, a annoncé aujourd’hui la disponibilité d’un connecteur préconçu pour IBM Watson Assistant. Le connecteur tire parti de l’architecture BYOB™ (Bring Your Own Bot ou Apportez votre propre bot) […] Lire la suite »

eGain stellt für intelligenteren Service Connector zu IBM Watson Assistant bereit

SUNNYVALE, Kalifornien, Sept. 07, 2022 (GLOBE NEWSWIRE) — eGain Corporation (NASDAQ: EGAN), der führende Anbieter von Wissensautomatisierungsplattformen für die Kundenbindung, gab heute die Verfügbarkeit eines vorgefertigten Connectors für IBM Watson Assistant bekannt. Der Connector nutzt die einzigartige BYOB™-Architektur (Bring Your Own Bot) von eGain, die es Geschäftsanwendern ermöglicht, den Watson Assistant […] Lire la suite »

Keep Petfood For Pets – Not for Fuel Tanks

Brussels, Sept. 07, 2022 (GLOBE NEWSWIRE) — Keep Petfood For Pets – Not for Fuel Tanks FEDIAF, Brussels, 7 September 2022 – There are more than 90 million European households benefiting from the love and companionship of over 300 million pets. They may soon face a big challenge: keeping them […] Lire la suite »

Protector Completes Acceptance Test Procedures

SAN DIEGO, Sept. 07, 2022 (GLOBE NEWSWIRE) — Acceptance Test Procedures (ATP) for the first Protector RG Mk1 Remotely Piloted Aircraft (RPA) system was completed on Aug. 26, 2022. Completion of ATP allows for the official hand-over of the aircraft to the UK Royal Air Force (RAF), the launch customer of the […] Lire la suite »

Israel Hotel Investment Summit 2022 Provides In-Depth Analysis of Foreign Investment Opportunities into the Israel Hospitality Sector

LONDON, Sept. 07, 2022 (GLOBE NEWSWIRE) — Questex, a leading information services and events company and the team behind the industry-leading International Hospitality Investment Forum (IHIF), today launches the third Israel Hotel Investment Summit (IHIS) in partnership with the Israel Ministry of Tourism. IHIS will be hosted at the InterContinental […] Lire la suite »

Neovii and Fosun Pharma Enter Into an Exclusive Agreement

ST. GALLEN, Switzerland, Sept. 07, 2022 (GLOBE NEWSWIRE) — Neovii Pharmaceuticals AG (“Neovii”), a Swiss based global specialty-care biopharmaceutical company, and Shanghai Fosun Pharmaceutical Industry Development Co. Ltd (“Fosun Pharma Industry”), a subsidiary of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (“Fosun Pharma”, Stock Code: 600196.SH, 02196.HK), a global pharmaceutical and […] Lire la suite »

OKYO Pharma Limited: Result of Annual General Meeting

LONDON and NEW YORK, Sept. 07, 2022 (GLOBE NEWSWIRE) — The board of directors of OKYO Pharma Limited (LSE: OKYO; NASDAQ: OKYO), a bio-pharmaceutical company focused on developing an innovative approach to dry eye care and ocular pain, is pleased to announce that at the Annual General Meeting (“AGM“) of […] Lire la suite »

High Q Technologies Inc. Hires Vice President, Research and Development and Announces Additional Recent Appointments to Support Rapid Growth

WATERLOO, Ontario, Sept. 07, 2022 (GLOBE NEWSWIRE) — High Q Technologies Inc. is an innovative life sciences tool company providing drug hunters and structural biologists with highly sensitive, quantum-enabled EPR systems to solve historically complex problems in protein dynamics. The company is pleased to announce the appointment of Andrew Wiles […] Lire la suite »

VisionH2 Expands Renewable Energy Hub Development

JERSEY CITY, N.J., Sept. 07, 2022 (GLOBE NEWSWIRE) —  Vision Hydrogen Corporation (OTCQB:VIHD) (“VisionH2” or the “Company”) is pleased to announce it has secured an additional 2.1 hectares (20,670 square metres) of prime industrial lands contiguous to its existing 14.3 hectares green energy hub development in the North Sea Port […] Lire la suite »

The Metals Company Subsidiary, NORI, Receives ISA Recommendation to Commence Pilot Nodule Collection Trials in the Clarion Clipperton Zone of the Pacific Ocean

The completion of the ISA’s review of the Collector Test Environmental Impact Statement (EIS) paves the way for TMC subsidiary, Nauru Ocean Resources Inc (NORI), to conduct its planned pilot collection system trials on its NORI-D exploration area in the Clarion Clipperton Zone of the Pacific Ocean beginning later this […] Lire la suite »

Amolyt Pharma organise un événement hybride avec un leader d’opinion sur son traitement potentiel pour l’hypoparathyroïdie, AZP-3601, le 12 septembre à 13h30 CT (14h30 ET/ 20h30 CET) à Austin au Texas (É.-U.)

LYON, France et CAMBRIDGE, Massachusetts, 07 sept. 2022 (GLOBE NEWSWIRE) — Amolyt Pharma, société spécialisée dans le développement de peptides thérapeutiques ciblant les maladies endocriniennes rares, a annoncé ce jour qu’elle organisait un événement hybride (en présentiel et virtuel) avec un leader d’opinion sur son traitement potentiel pour l’hypoparathyroïdie, AZP-3601. […] Lire la suite »

Amolyt Pharma to Host Hybrid Key Opinion Leader Event on its Potential Hypoparathyroidism Treatment, AZP-3601, on Monday, September 12th at 1:30pm CT/2:30pm ET in Austin, Texas

LYON, France and CAMBRIDGE, Mass., Sept. 07, 2022 (GLOBE NEWSWIRE) — Amolyt Pharma, a global company specializing in the development of therapeutic peptides for rare endocrine and related diseases, today announced it will host a hybrid (in-person and virtual) key opinion leader event on the Company’s potential hypoparathyroidism treatment, AZP-3601, […] Lire la suite »